Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Population Screening Market Size Changed, over the years?

The size of the population screening market has seen significant expansion in recent years. Expansion is projected to continue, with the value predicted to rise from $29.31 billion in 2024 to $31.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. The number of elements driving this historic period of growth includes disease prevention initiatives, government health care strategies, escalating healthcare costs, and a surge in disease awareness.

How Much Will the Population Screening Market Be Worth in 2029?

In the upcoming years, the market size of population screening is anticipated to witness significant growth, expanding to $41.51 billion by 2029 with a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period can be credited to the shift towards personalized medicine, an aging population, chronic diseases, adoption of AI and data analytics, and broader screening access. Key trends identified for the forecast period incorporate advancements in medical technology, swell in genomics and precision screening, telehealth and distance screening, multi-disease screening panels, and growth in health equality and accessibility.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

Which is the Largest Company in the Population Screening Market?

Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

What Are the Main Market Drivers in the Population Screening Industry?

The upward trend in cancer rates is projected to bolster the expansion of the population screening market. Cancer is a disease where certain cells in the human organism proliferate improperly and infiltrate other body parts. Early detection of cancer through population screening can potentially improve treatment results and prognosis. For example, data from the American Cancer Society Inc., a volunteer health organization in the US, revealed in January 2023 that there were 608,570 cancer fatalities in 2022 and an approximated 1.9 million new cancer instances, compared to the 606,520 cancer deaths in 2021. Consequently, the escalating incidence of cancer is fuelling the development of the population screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

How Is the Population Screening Market Segments Structured?

The population screening market covered in this report is segmented –

1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

2) By Gender: Male, Female

3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

4) By Business: Hospitals, Research Institutes, Diagnostic Labs

Subsegments:

1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

What Strategic Trends Are Transforming the Population Screening Market?

In an effort to enhance early detection and promote better infant health outcomes, large corporations functioning in the population screening industry are bringing forth improved services such as newborn mass screening. This specific type of screening is a healthcare initiative for newborns, testing them soon after birth for a myriad of disorders which may not be detectable at birth but could cause serious health issues if left unaddressed. These disorders can be genetic, metabolic, hormonal or functional. In a recent development, Shimadzu Techno-Research Inc., which is a subsidiary of Japan’s Shimadzu Corporation known for producing precision instruments, in the month of May 2024, rolled out a new service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. The new service will screen for medical conditions like combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which, although currently impact a small proportion of newborns, mandate instant treatment following diagnosis.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

Which Global Regions Offer the Highest Growth in the Population Screening Market?

North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

This Report Delivers Insight On:

1. How big is the population screening market, and how is it changing globally?

2. Who are the major companies in the population screening market, and how are they performing?

3. What are the key opportunities and risks in the population screening market right now?

4. Which products or customer segments are growing the most in the population screening market?

5. What factors are helping or slowing down the growth of the population screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model